This trial is active and currently recruiting.
Who Can Participate
People who have the following may be eligible to participate: (1) poorly controlled asthma for at least 12 months, (2) a physician-prescribed asthma controller with medium- or high-dose inhaled corticosteroid (ICS) such as Flovent®, (3) an additional controller inhaler, including combination inhalers such as Symbicort® or Advair®.
Age: 18-80 Gender: Any Gender
Estimated Time Commitment
19 visits over 69-71 weeks